SEC Tracker
Get the app

Interpace Biosciences IDXG

Interpace Biosciences: signs a material agreement, reports an executive or board change and amends its charter or bylaws

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
  • Signs a material agreement (1.01)
  • Reports an executive or board change (5.02)
  • Amends its charter or bylaws (5.03)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Interpace Biosciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Global Innovative Platforms GIPL public float $3M, Sep 30, 2025
  2. ENDRA Life Sciences NDRA public float $3M, Jun 30, 2025
  3. Bluejay Diagnostics BJDX public float $3M, Jun 30, 2025
  4. Stimcell Energetics STME public float $2M, Nov 30, 2025
  5. LogicMark LGMK public float $2M, Jun 30, 2025